About DEXORGEN INC.
Dexorgen, Inc. is an advanced biotechnology company based in Maryland, specializing in providing live cell-based assays for drug discovery and compound screening, particularly in GPCR and PDE cell lines. They offer high-throughput solutions for scientific research and have participated in federal collaborations such as Tox21.
Drug discovery and compound screeningLive cell-based assays for GPCR and PDE targetsDevelopment of biochemical assay kits and specialty dyesAssay development and mechanism of action characterizationPrimary cell culture and cell engineering with CRISPR and shRNAContract research and collaborations with pharmaceutical, biotech, and academic institutions
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $25K | |
| Federal contract award | Department of Health and Human Services | $24K | |
| Federal contract award | Department of Health and Human Services | $24K | |
| Federal contract award | Department of Health and Human Services | $15K | |
| Federal contract award | Department of Health and Human Services | $35K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DEXORGEN INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.